Newsletter registration

Используя наш сайт, Вы соглашаетесь с тем, что в целях обеспечения оптимального сервиса на Вашем компьютере будут сохраняться файлы Cookie и будет использоваться служба Google Analytics. Более подробную информацию об этом Вы найдетездесь.
Австрия
Мост к новым рынкам

Targeted inhibitors help against cancer – removal is harmful

"There are an increasing number of outbreaks of cancer, especially blood cancer, in which the hyperactivity of Tyk2 is the cause“, explained Mathias Müller of the Institute of Animal Breeding and Genetics at the University of Veterinary Medicine in Vienna. The signal conveyors can also trigger excessive immune reactions.

For this reason, substances are being developed which inhibit the previously known function of Tyk2 (or "kinase"). Signals are transmitted by attaching a “flag” (phosphate residue) to other proteins. Such medicines would be helpful in the fight against cancer and inflammation-related illnesses, the researchers say.

However, complications could arise in light of the fact that Tyk2 makes a considerable contribution to the maturing and activation of “natural killer cells”.  

In fact, mice in which completely lacked Tyk2 had killer cells which were baldy prepared, and could no longer control cancer growth. However, in animals in which Tyk2 was present but its kinase activity was inactivated, cancer growth was strongly suppressed and the natural killer cells retained their ability to effectively kill the cancer cells.

"Medicines aiming to inhibit kinase activity do not damage the work of the immune system“, explained Birgit Strobl of the Department for Molecular Genetics at the University of Veterinary Medicine in Vienna. Instead, they are more promising for cancer therapy than was originally thought. 

Share on Facebook Share on Facebook Share on Twitter Share on Twitter

Отзывы

Мероприятия

Познакомьтесь с нами в рамках мероприятий, семинаров и выставок по всему миру

Austria Map

Find the perfect location for your company

Австрия занимает ключевую позицию для бизнеса между Востоком и Западом. Мы высоко ценим превосходную инфраструктуру, в особенной мере отличное воздушное сообщение, высококвалифицированные трудовые кадры, а также первоклассное качество жизни в Вене.

ЛУКОЙЛ

Lukoil Logo
Все отзывы

Новости Австрии, как площадки для бизнеса

September 12-14, 2018: 1MillionStartups Global Conference in Vienna

The Viennese startup hub weXelerate is hosting the very first 1MillionStartups Global Conference from September 12-14, 2018.

Testing the potential early detection of ovarian cancer

About 75 percent of the cases of extremely aggressive ovarian cancer (ovarian carcinoma) originally arise in the fallopian tube. Currently there are no possibilities to detect this at an early stage. A new catheter system developed by Viennese scientists could represent a new possibility to deal with this.

Все новости